Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma - Elsawy, Mahmoud; Chavez, Julio C.; Avivi, Irit; Larouche, Jean-François; Wannesson, Luciano; Cwynarski, Kate; Osman, Keren; Davison, Kelly; Rudzki, Jakob D.; Dahiya, Saurabh; Dorritie, Kathleen; Jaglowski, Samantha; et al. (Blood, 2022)
Online verfügbar 19 July 2022, Version des Artikels 24 November 2022